S&P 500   3,321.46 (-0.01%)
DOW   29,140.31 (-0.16%)
QQQ   224.25 (+0.17%)
AAPL   318.71 (+0.32%)
FB   220.20 (-0.51%)
MSFT   166.31 (+0.37%)
GOOGL   1,487.87 (+0.25%)
AMZN   1,885.53 (-0.10%)
CGC   24.37 (+1.04%)
NVDA   252.57 (+1.01%)
BABA   219.63 (-1.23%)
MU   59.19 (+0.03%)
GE   11.71 (+2.99%)
TSLA   565.50 (-0.71%)
AMD   51.44 (+0.02%)
T   38.70 (-0.87%)
ACB   2.04 (+0.00%)
F   9.10 (-0.66%)
NFLX   340.93 (+4.58%)
BAC   34.15 (-0.61%)
DIS   142.10 (-1.33%)
GILD   63.75 (+0.49%)
S&P 500   3,321.46 (-0.01%)
DOW   29,140.31 (-0.16%)
QQQ   224.25 (+0.17%)
AAPL   318.71 (+0.32%)
FB   220.20 (-0.51%)
MSFT   166.31 (+0.37%)
GOOGL   1,487.87 (+0.25%)
AMZN   1,885.53 (-0.10%)
CGC   24.37 (+1.04%)
NVDA   252.57 (+1.01%)
BABA   219.63 (-1.23%)
MU   59.19 (+0.03%)
GE   11.71 (+2.99%)
TSLA   565.50 (-0.71%)
AMD   51.44 (+0.02%)
T   38.70 (-0.87%)
ACB   2.04 (+0.00%)
F   9.10 (-0.66%)
NFLX   340.93 (+4.58%)
BAC   34.15 (-0.61%)
DIS   142.10 (-1.33%)
GILD   63.75 (+0.49%)
S&P 500   3,321.46 (-0.01%)
DOW   29,140.31 (-0.16%)
QQQ   224.25 (+0.17%)
AAPL   318.71 (+0.32%)
FB   220.20 (-0.51%)
MSFT   166.31 (+0.37%)
GOOGL   1,487.87 (+0.25%)
AMZN   1,885.53 (-0.10%)
CGC   24.37 (+1.04%)
NVDA   252.57 (+1.01%)
BABA   219.63 (-1.23%)
MU   59.19 (+0.03%)
GE   11.71 (+2.99%)
TSLA   565.50 (-0.71%)
AMD   51.44 (+0.02%)
T   38.70 (-0.87%)
ACB   2.04 (+0.00%)
F   9.10 (-0.66%)
NFLX   340.93 (+4.58%)
BAC   34.15 (-0.61%)
DIS   142.10 (-1.33%)
GILD   63.75 (+0.49%)
S&P 500   3,321.46 (-0.01%)
DOW   29,140.31 (-0.16%)
QQQ   224.25 (+0.17%)
AAPL   318.71 (+0.32%)
FB   220.20 (-0.51%)
MSFT   166.31 (+0.37%)
GOOGL   1,487.87 (+0.25%)
AMZN   1,885.53 (-0.10%)
CGC   24.37 (+1.04%)
NVDA   252.57 (+1.01%)
BABA   219.63 (-1.23%)
MU   59.19 (+0.03%)
GE   11.71 (+2.99%)
TSLA   565.50 (-0.71%)
AMD   51.44 (+0.02%)
T   38.70 (-0.87%)
ACB   2.04 (+0.00%)
F   9.10 (-0.66%)
NFLX   340.93 (+4.58%)
BAC   34.15 (-0.61%)
DIS   142.10 (-1.33%)
GILD   63.75 (+0.49%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:IPHI - Inphi Stock Price, Forecast & News

$83.90
+1.32 (+1.60 %)
(As of 01/23/2020 02:20 PM ET)
Today's Range
$81.95
Now: $83.90
$84.46
50-Day Range
$68.05
MA: $76.31
$83.27
52-Week Range
$33.80
Now: $83.90
$84.97
Volume12,629 shs
Average Volume606,234 shs
Market Capitalization$3.83 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.61
Inphi Corporation provides high-speed analog and mixed signal semiconductor solutions for the communications, datacenter, and computing markets worldwide. Its analog and mixed signal semiconductor solutions offer high signal integrity at various data speeds and reduce system power consumption. The company's semiconductor solutions address bandwidth bottlenecks in networks, maximize throughput and minimize latency in computing environments, and enable the rollout of communications and datacenter infrastructures. Read More…

Industry, Sector and Symbol

Industry Semiconductors & related devices
Sub-IndustrySemiconductors
SectorComputer and Technology
CUSIP45772F10
Phone408-217-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$294.49 million
Cash Flow$1.32 per share
Book Value$8.31 per share

Profitability

Net Income$-95,750,000.00

Miscellaneous

Employees580
Market Cap$3.83 billion
Next Earnings Date2/4/2020 (Confirmed)
OptionableOptionable

Receive IPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for IPHI and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

Inphi (NYSE:IPHI) Frequently Asked Questions

What is Inphi's stock symbol?

Inphi trades on the New York Stock Exchange (NYSE) under the ticker symbol "IPHI."

How were Inphi's earnings last quarter?

Inphi Co. (NYSE:IPHI) posted its earnings results on Tuesday, October, 29th. The semiconductor company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.37 by $0.08. The semiconductor company earned $94.23 million during the quarter, compared to analysts' expectations of $90.09 million. Inphi had a negative net margin of 23.23% and a positive return on equity of 0.46%. Inphi's quarterly revenue was up 20.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.30 EPS. View Inphi's Earnings History.

When is Inphi's next earnings date?

Inphi is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Inphi.

How can I listen to Inphi's earnings call?

Inphi will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Inphi issued on next quarter's earnings?

Inphi updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $0.40-0.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.43. The company issued revenue guidance of $97.8-101.8 million, compared to the consensus revenue estimate of $95.35 million.

What price target have analysts set for IPHI?

14 brokers have issued 1 year price objectives for Inphi's shares. Their forecasts range from $45.00 to $100.00. On average, they expect Inphi's stock price to reach $75.69 in the next twelve months. This suggests that the stock has a possible downside of 10.2%. View Analyst Price Targets for Inphi.

What is the consensus analysts' recommendation for Inphi?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inphi in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inphi.

Has Inphi been receiving favorable news coverage?

News coverage about IPHI stock has trended somewhat positive recently, InfoTrie reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Inphi earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave media stories about the semiconductor company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Inphi.

Who are some of Inphi's key competitors?

What other stocks do shareholders of Inphi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inphi investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Veeva Systems (VEEV), Cisco Systems (CSCO), Skyworks Solutions (SWKS), CVS Health (CVS), Netflix (NFLX), Micron Technology (MU) and Intel (INTC).

Who are Inphi's key executives?

Inphi's management team includes the folowing people:
  • Dr. Ford G. Tamer, Pres, CEO & Director (Age 57)
  • Mr. John S. Edmunds, Sr. VP, CFO, Chief Accounting Officer & Sec. (Age 62)
  • Dr. Ron Torten, Sr. VP of Operations & Information Technology (Age 52)
  • Mr. Richard T. Ogawa, Gen. Counsel (Age 56)
  • Mr. Charles Roach, Sr. VP of Worldwide Sales (Age 49)

Who are Inphi's major shareholders?

Inphi's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Scout Investments Inc. (0.19%), Tributary Capital Management LLC (0.08%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), IFP Advisors Inc (0.00%), Harel Insurance Investments & Financial Services Ltd. (0.00%) and Carroll Financial Associates Inc. (0.00%). Company insiders that own Inphi stock include Charles Roach, Chenming Hu, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten, Sam Srinivasan and William J Ruehle. View Institutional Ownership Trends for Inphi.

Which institutional investors are selling Inphi stock?

IPHI stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc. and Tributary Capital Management LLC. Company insiders that have sold Inphi company stock in the last year include Charles Roach, Chenming Hu, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten and William J Ruehle. View Insider Buying and Selling for Inphi.

Which institutional investors are buying Inphi stock?

IPHI stock was purchased by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., IFP Advisors Inc, Carroll Financial Associates Inc. and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Inphi stock in the last two years include Ford Tamer and Sam Srinivasan. View Insider Buying and Selling for Inphi.

How do I buy shares of Inphi?

Shares of IPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Inphi's stock price today?

One share of IPHI stock can currently be purchased for approximately $84.27.

How big of a company is Inphi?

Inphi has a market capitalization of $3.85 billion and generates $294.49 million in revenue each year. The semiconductor company earns $-95,750,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. Inphi employs 580 workers across the globe.View Additional Information About Inphi.

What is Inphi's official website?

The official website for Inphi is http://www.inphi.com/.

How can I contact Inphi?

Inphi's mailing address is 2953 Bunker Hill Lane Suite 300, Santa Clara CA, 95054. The semiconductor company can be reached via phone at 408-217-7300 or via email at [email protected]


MarketBeat Community Rating for Inphi (NYSE IPHI)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  664 (Vote Outperform)
Underperform Votes:  432 (Vote Underperform)
Total Votes:  1,096
MarketBeat's community ratings are surveys of what our community members think about Inphi and other stocks. Vote "Outperform" if you believe IPHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: S&P 500 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel